Mood Stabilizers and Ion Regulation

REFERENCES

• Ballenger JC, Post RM. Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry 1980;137:782–90.
   PubMed Web of Science ®Google Scholar
• Lerer B, Moore N, Meyendorff E, Cho SR, Gershon S. Carba-mazepine versus lithium in mania: a double-blind study. J Clin Psychiatry 1987;48:89–93.
   PubMed Web of Science ®Google Scholar
• Pope HG Jr, McElroy SL, Keck PE Jr, Hudson JI. Valproate in the treatment of acute mania: a placebo-controlled study. Arch Gen Psychiatry 1991;48:62–8.
   Google Scholar
• Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994;271:918–24.
   PubMed Web of Science ®Google Scholar
• Chouinard G, Young SN, Annable L. Antimanic effect of clo-nazepam. Biol Psychiatry 1983;18:451–66.
   PubMed Web of Science ®Google Scholar
• Modell JG, Lenox RH, Weiner S. Inpatient clinical trial of lorazepam for the management of manic agitation. J Clin Psychopharmacol 1985;5:109–13.
   Google Scholar
• Bradwejn J, Shriqui C, Koszycki D, Meterissian G. Double- blind comparison of the effects of clonazepam and lorazepam in acute mania. J Clin Psychopharmacol 1990;10:403–8.
   PubMed Web of Science ®Google Scholar
• Sachs GS. Use of clonazepam for bipolar affective disorder. J Clin Psychiatry 1990;51(suppl):31–4.
   Google Scholar
• Edwards R, Stephenson U, Flewett T. Clonazepam in acute mania: a double blind trial. Aust NZ J Psychiatry 1991;25:238–42.
   PubMed Web of Science ®Google Scholar
• Botta T, He B, Hillaire-Buys D, Barbe A, Alric R, Pouget R, et al. Clonazepam in acute mania: time-blind evaluation of clinical response and concentrations in plasma. J Affect Dis-ord 1995;36:21–7.
   Google Scholar
• Johnson G, Gershon S, Burdock EI, Floyd A, Hekimian L. Comparative effects of lithium and chlorpromazine in the treatment of acute manic states. Br J Psychiatry 1971;119:267–76.
   PubMed Web of Science ®Google Scholar
• Goodwin FK, Zis AP. Lithium in the treatment of mania: comparisons with neuroleptics. Arch Gen Psychiatry 1979; 36:840–4.
   PubMed Web of Science ®Google Scholar
• Tohen M, Zarate CA Jr, Centorrino F, Hegarty JI, Froeschl M, Zarate SB. Risperidone in the treatment of mania. J Clin Psychiatry 1996;57:249–53.
   PubMed Web of Science ®Google Scholar
• Ghaemi SN, Sachs GS, Baldassano CF, Truman CJ. Acute treatment of bipolar disorder with adjunctive risperidone in outpatients. Can J Psychiatry 1997;42:196–9.
   PubMed Web of Science ®Google Scholar
• Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KN, Daniel DG, et al. Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry 1999;156:702–9.
   PubMed Web of Science ®Google Scholar
• Dubovsky SL, Franks RD, Allen S, Murphy J. Calcium antagonists in mania: a double-blind study of verapamil. Psychiatry Res 1986;18:309–20.
   PubMed Web of Science ®Google Scholar
• Giannini AJ, Houser WL Jr, Loiselle RH, Giannini MC, Price WA. Antimanic effects of verapamil. Am J Psychiatry 1984; 141:1602–3.
   PubMed Web of Science ®Google Scholar
• El-Mallakh RS, Jaziri WA. Calcium channel blockers in affective illness: role of sodium-calcium exchange. J Clin Psy-chopharmacol 1990;10:203–6.
   PubMed Web of Science ®Google Scholar
• Bunney WE Jr, Goodwin FK, Davis JM, Fawcett JA. A behavioral-biochemical study of lithium treatment. Am J Psychiatry 1968;125:499–512.
   Google Scholar
• Angst J, Weis P, Grof P, Baastrup PC, Schou M. Lithium prophylaxis in recurrent affective disorders. Br J Psychiatry 1970;116:604–14.
   PubMed Web of Science ®Google Scholar
• Goodwin FK, Murphy DK, Bunney WE Jr. Lithium carbonate treatment of manic-depressive illness. Lancet 1971;1:1319–25.
   Google Scholar
• El-Mallakh RS. Lithium: actions and mechanisms. Washington, DC: American Psychiatric Press, 1996.
   Google Scholar
• Post RM, Uhde TW, Ballenger JC, Squillace KM. Prophylactic efficacy of carbamazepine in manic-depressive illness. Am J Psychiatry 1983;140:1602–4.
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Delucchi GA. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry 1990;147:431–4.
   PubMed Web of Science ®Google Scholar
• Post RM, Ketter TA, Denicoff K, Pazzaglia PJ, Leverich GS, Marangell LB, et al. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology (Berl) 1996;128:115–29.
   PubMed Web of Science ®Google Scholar
• Manji HK, Lenox RH. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry 1999; 46:1328–1351.
   PubMed Web of Science ®Google Scholar
• Stoll AL, Severus WE. Mood stabilizers: shared mechanisms of action at postsynaptic signal-transduction and kindling processes. Harvard Rev Psychiatry 1996;4:77–89.
   PubMed Web of Science ®Google Scholar
• Berridge MJ, Downes CP, Hanley MR. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J 1982;206:587–95.
   PubMed Web of Science ®Google Scholar
• Sherman WR, Munsell LY, Gish BG, Honchar MP. Effects of systemically administered lithium on phosphoinositide metabolism in rat brain, kidney, and testis. J Neurochem 1985; 44:798–807.
   PubMed Web of Science ®Google Scholar
• Parthasarathy L, Vadnal RE, Parthasarathy R, Devi CS. Biochemical and molecular properties of lithium-sensitive myoinositol monophosphatase. Life Sci 1994;54:1127–42.
   PubMed Web of Science ®Google Scholar
• Vadnal R, Parthasarathy R. Myoinositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate. Neuropsychopharmacology 1995;12:277–85.
   PubMed Web of Science ®Google Scholar
• Schreiber G, Avissar S, Aulakh CS, Murphy DL. Lithium-selective alteration of the function of brain versus cardiac Cs protein. Neuropharmacology 1990;29:1067–71.
   PubMedGoogle Scholar
• Li PP, Young LT, Tam YK, Sibony D, Warsh JJ. Effects of chronic lithium and carbamazepine treatment on G-protein subunit expression in rat cerebral cortex. Biol Psychiatry 1993;34:162–70.
   Google Scholar
• Manji HK, Chen G, Shimon H, Hsiao JK, Potter WZ, Bel-maker RH. Guanine nucleotide–binding proteins in bipolar affective disorder: effects of long-term lithium treatment. Arch Gen Psychiatry 1995;52:135–44.
   PubMedGoogle Scholar
• Jakobsen SN, Wiborg O. Selective effects of long-term lithium and carbamazepine administration on G-protein subunit expression in rat brain. Brain Res 1998;780:46–55.
   PubMed Web of Science ®Google Scholar
• Chen G, Manji HK, Wright CB, Hawver DB, Potter WZ. Effects of valproic acid on p-adrenergic receptors, G-proteins, and adenylyl cyclase in rat C6 glioma cells. Neuropsycho-pharmacology 1996;15:271–80.
   PubMed Web of Science ®Google Scholar
• Lesch KP, Aulakh CS, Tolliver TJ, Hill JL, Wolozin BL, Murphy DL. Differential effects of long-term lithium and carbamazepine administration on Gsa and Gin protein in rat brain. Eur J Pharmacol 1991;207:355–9.
   Google Scholar
• Lenox RH, Watson DG, Patel J, Ellis J. Chronic lithium administration alters a prominent PKC substrate in rat hippocampus. Brain Res 1992;570:333–40.
   PubMedGoogle Scholar
• Manji HK, Etcheberrigaray R, Chen G, Olds JL. Lithium decreases membrane-associated protein kinase C in hippocampus: selectivity for the a isozyme. J Neurochem 1993;61:2303–10.
   PubMedGoogle Scholar
• Manji HK, Potter WZ, Lenox RH. Signal transduction pathways: molecular targets for lithium’s actions. Arch Gen Psychiatry 1995;52:531–43.
   PubMed Web of Science ®Google Scholar
• Chen G, Manji HK, Hawver DB, Wright CB, Potter WZ. Chronic sodium valproate selectively decreases protein kinase C a and e in vitro. J Neurochem 1994;63:2361–4.
   PubMedGoogle Scholar
• Watson DG, Watterson JM, Lenox RH. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C–mediated mood stabilizers. J Pharmacol Exp Ther 1998;285:307–16.
   PubMedGoogle Scholar
• Morishita S, Watanabe S. The direct effect of lithium and carbamazepine on protein kinase C in rat brain. Jpn J Psychiatry Neurol 1994;48:123–6.
   Google Scholar
• Jensen JB, Mork A. Altered protein phosphorylation in the rat brain following chronic lithium and carbamazepine treatments. Eur Neuropsychopharmacol 1997;7:173–9.
   Google Scholar
• Ozaki N, Chuang DM. Lithium increases transcription factor binding to AP-1 and cyclic AMP–responsive element in cultured neurons and rat brain. J Neurochem 1997;69:2336–44.
   PubMed Web of Science ®Google Scholar
• Asghari V, Wang JF, Reiach JS, Young LT. Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells. Brain Res Mol Brain Res 1998;58:95–102.
   PubMedGoogle Scholar
• Chen G, Yuan PX, Jiang YM, Huang LD, Manji HK. Lithium increases tyrosine hydroxylase levels both in vivo and in vitro. J Neurochem 1998;70:1768–71.
   Google Scholar
• Yuan PX, Chen G, Huang LD, Manji HK. Lithium stimulates gene expression through the AP-1 transcription factor pathway. Brain Res Mol Brain Res 1998;58:225–30.
   Google Scholar
• Chen G, Yuan PX, Jiang YM, Huang LD, Manji HK. Valproate robustly enhances AP-1 mediated gene expression. Brain Res Mol Brain Res 1999;64:52–8.
   PubMedGoogle Scholar
• Hedgepeth CM, Conrad LJ, Zhang J, Huang HC, Lee VM, Klein PS. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol 1997;185:82–91.
   PubMed Web of Science ®Google Scholar
• Chen G, Huang LD, Jiang YM, Manji HK. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase–3. J Neurochem 1999;72:1327–30.
   PubMed Web of Science ®Google Scholar
• Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. J Clin Psychiatry 1999;60(suppl 2):27–39.
   Google Scholar
• Civan MM, Shporer M. Physical state of cell sodium. Curr Top Membr Transp 1989;34:1–19.
   Google Scholar
• Kuffler SW, Nichols JC, Martin AR. From neuron to brain: a cellular approach to the function of the nervous system. 2nd ed. Sunderland, Massachusetts: Sinauer, 1984.
   Google Scholar
• Astrup J, Sørensen PM, Sørensen HR. Oxygen and glucose consumption related to Na+-K+ transport in canine brain. Stroke 1981;12:726–30.
   PubMed Web of Science ®Google Scholar
• Katz B, Miledi R. Ionic requirements of synaptic transmitter release. Nature 1967;215:651.
   PubMed Web of Science ®Google Scholar
• Katz B, Miledi R. A study of synaptic transmission in the absence of nerve impulses. J Physiol 1967;192:407–36.
   PubMed Web of Science ®Google Scholar
• Katz B, Miledi R. The release of acetylcholine from nerve endings by graded electric pulses. Proc R Soc Lond B Biol Sci 1967;167:23–38.
   PubMedGoogle Scholar
• Baker PF Transport and metabolism of calcium ions in nerve. ProgBiophys Mol Biol 1972;24:177–223.
   PubMedGoogle Scholar
• Blaustein MP. The interrelationship between sodium and calcium fluxes across cell membranes. Rev Physiol Biochem Pharmacol 1974;70:33–82.
   PubMedGoogle Scholar
• Baker PF, Blaustein MP. Sodium-dependent uptake of calcium by crab nerve. Biochim Biophys Acta 1968; 150:167–70.
   PubMed Web of Science ®Google Scholar
• Blaustein MP, Wiesmann WP Effect of sodium ions on calcium movements in isolated synaptic terminals. Proc Natl Acad Sci USA 1970;66:664–71.
   Google Scholar
• Blaustein MP, Russell JM, Weer P. Calcium efflux from inter- nally dialyzed squid axons: the influence of external and internal cations. J Supramol Struct 1974;2:558–81.
   PubMedGoogle Scholar
• Blaustein MP, Ratzlaff RW, Schweitzer ES. Control of intracellular calcium in presynaptic nerve terminals. Fed Proc 1980;39:2790–5.
   Google Scholar
• Racker E. Fluxes of Ca2+ and concepts. Fed Proc 1980;39:2422–6.
   PubMedGoogle Scholar
• Janis RA, Silver PJ, Triggle DJ. Drug action and cellular calcium regulation. Adv Drug Res 1987;16:309–591.
   Google Scholar
• Zucker RS, Lando L. Mechanism of transmitter release: voltage hypothesis and calcium hypothesis. Science 1986;231:574–9.
   PubMed Web of Science ®Google Scholar
• Miledi R. Transmitter release induced by injection of calcium ions into nerve terminals. Proc R Soc Lond B Biol Sci 1973; 183:421–5.
   PubMed Web of Science ®Google Scholar
• Carafoli E, Crompton M. The regulation of intracellular calcium by mitochondria. Ann NY Acad Sci 1978;307:269–84.
   PubMedGoogle Scholar
• Vincenzi FF, Larsen FL. The plasma membrane calcium pump: regulation by a soluble Ca2+ binding protein. Fed Proc 1980;39:2427–31.
   PubMedGoogle Scholar
• Huxley AF, Stampfli R. Effect of potassium and sodium on resting and action potentials of single myelinated nerve fibers. J Physiol (Lond) 1951;112:496–508.
   Google Scholar
• Robinson JD. Vanadate inhibition of brain (Ca + Mg)-ATPase. NeurochemRes 1981;6:225–232.
   Google Scholar
• Rasmussen H. The calcium messenger system (2). N Engl J Med 1986;314:1164–70.
   PubMed Web of Science ®Google Scholar
• Keynes RS, Swan RC. The permeability of frog muscle fibers to lithium ions. J Physiol (Lond) 1959;147:626–38.
   Google Scholar
• Carmiliet EE. Influence of lithium ions on the transmembrane potential and cation content of cardiac cells. J Gen Physiol 1964;47:501–30.
   Google Scholar
• El-Mallakh RS. The ionic mechanism of lithium action. Lithium 1990;1:87–92.
   Google Scholar
• Armett CJ, Ritchie JM. On the permeability of mammalian non-myelinated fibers to sodium and to lithium ions. J Physiol (Lond) 1963;165:130–40.
   Google Scholar
• Heurteaux C, Baumann N, Lachapelle F, Wissocq JC, Thel-lier M. Lithium distribution in the brain of normal mice and of “quaking” dysmyelinating mutants. J Neurochem 1986; 46:1317–21.
   Google Scholar
• Okamoto Y, Kagaya A, Jitsuiki H, Zensho H, Nishida A, Hori-guchi J, et al. Chronic lithium treatment blunts an excessive noradrenergic response in rat hippocampal slices [Abstract]. Bipolar Disord 1999;1(suppl 1):45.
   Google Scholar
• El-Mallakh RS. Complications of concurrent lithium and electroconvulsive therapy: a review of clinical material and theoretical considerations. Biol Psychiatry 1988;23:595–601.
   PubMed Web of Science ®Google Scholar
• Schmalzing G. Coupling of Li+ distribution to the plasma membrane potential of rat cortical synaptosomes. J Biol Chem 1986;261:650–6.
   Google Scholar
• Kabakov AY, Karkanias NB, Lenox RH, Papke RL. Synapse-specific accumulation of lithium in intracellular microdo-mains: a model for uncoupling coincidence detection in the brain. Synapse 1998;28:271–9.
   Google Scholar
• Wissocq JC, Laurent-Petterson M, Chauzy C, Delpech B, Thellier M. Attempting a subcellular localisation of lithium in cell cultures of human glioma and in oocytes of Xenopus laevis. In: Birch NJ, Padgham C, Hughes MS, eds. Lithium in medicine and biology. Carnforth, UK: Marius, 1993: 225–32.
   Google Scholar
• Renshaw PF, Wicklund S. In vivo measurement of lithium in humans by nuclear magnetic resonance spectroscopy. Biol Psychiatry 1988;23:465–75.
   PubMed Web of Science ®Google Scholar
• Komoroski RA, Newton JE, Walker E, Cardwell D, Jangan-nathan NR, Ramaprasad S, et al. In vivo NMR spectroscopy of lithium-7 in humans. Magn Reson Med 1990;15:347–56.
   Google Scholar
• Gyulai L, Wicklund SW, Greenstein R, Bauer MS, Ciccione P, Whybrow PC, et al. Measurement of tissue lithium concentration by lithium magnetic resonance spectroscopy in patients with bipolar disorder. Biol Psychiatry 1991;29:1161–70.
   Web of Science ®Google Scholar
• Kato T, Takahashi S, Inubushi T Brain lithium concentration by 7Li- and 1H-magnetic resonance spectroscopy in bipolar disorder. Psychiatry Res 1992;45:53–63.
   PubMed Web of Science ®Google Scholar
• Plenge P, Stensgaard A, Jensen HV, Thomsen C, Mellerup ET, Henriksen O. 24-hour lithium concentration in human brain studied by Li-7 magnetic resonance spectroscopy. Biol Psychiatry 1994;36:511–6.
   PubMed Web of Science ®Google Scholar
• Sachs GS, Renshaw PF, Lafer B, Stoll AL, Guimaraes AR, Rosenbaum JF, et al. Variability of brain lithium levels during maintenance treatment: a magnetic resonance spectroscopy study. Biol Psychiatry 1995;38:422–8.
   PubMedGoogle Scholar
• Friedman SM. Lithium substitution and the distribution of sodium in the rat tail artery. Circ Res 1974;34:168–75.
   PubMed Web of Science ®Google Scholar
• Haas M, Schooler J, Tosteson DC. Coupling of lithium to sodium transport in human red cells. Nature 1975;258:425–7.
   PubMed Web of Science ®Google Scholar
• Baer L, Kassir S, Fieve R. Lithium-induced changes in electrolyte balance and tissue electrolyte concentration. Psycho-pharmacologia 1970;17:216–24.
   Google Scholar
• Coppen A, Malleson A, Shaw DM. Effects of lithium carbonate on electrolyte distribution in man. Lancet 1965;1:682–3.
   Google Scholar
• Schauf CL, Davis FA, Marder J. Effects of carbamazepine on the ionic conductances of Myxicola giant axons. J Pharmacol Exp Ther 1974;189:538–43.
   PubMed Web of Science ®Google Scholar
• Willow M, Kuenzel EA, Catterall WA. Inhibition of voltage-sensitive sodium channels in neuroblastoma cells and synaptosomes by the anticonvulsant drugs diphenylhydantoin and carbamazepine. Mol Pharmacol 1984;25:228–34.
   PubMed Web of Science ®Google Scholar
• Elliott P. Action of antiepileptic and anaesthetic drugs on Na-and Ca-spikes in mammalian non-myelinated axons. Eur J Pharmacol 1990;175:155–63.
   Google Scholar
• Lang DG, Wang CM, Cooper BR. Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. J Pharmacol Exp Ther 1993;266:829–35.
   PubMed Web of Science ®Google Scholar
• Willow M, Catterall WA. Inhibition of binding of [3H]batra-chotoxinin A 20-a-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine. Mol Pharmacol 1982;22:627–35.
   PubMed Web of Science ®Google Scholar
• Catterall WA, Morrow CS, Daly JW, Brown GB. Binding of batrachotoxinin A 20-a-benzoate to a receptor site associated with sodium channels in synaptic nerve ending particles. J Biol Chem 1981;256:8922–7.
   Google Scholar
• McLean MJ, Macdonald RL. Carbamazepine and 10,11-epoxycarbamazepine produce use-and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther 1986;238:727–38.
   PubMed Web of Science ®Google Scholar
• Chapman A, Keane PE, Meldrum BS, Simiand J, Vernieres JC. Mechanism of anticonvulsant action of valproate. Prog Neurobiol 1982;19:315–59.
   PubMed Web of Science ®Google Scholar
• Loscher W. GABA in plasma and cerebrospinal fluid of different species: effects of-y-acetylenic GABA, -y-vinyl GABA and sodium valproate. J Neurochem 1979;32:1587–91.
   Google Scholar
• Macdonald RL, Bergey GK. Valproic acid augments GABA-mediated postsynaptic inhibition of cultured mammalian neurons. Brain Res 1979;170:558–62.
   Google Scholar
• Kerwin RW, Olpe HR, Schmutz M. The effect of sodium-n-dipropyl acetate on -y-aminobutyric acid–dependent inhibition in the rat cortex and substantia nigra in relation to its anticonvulsant activity. Br J Pharmacol 1980;71:545–51.
   Google Scholar
• Baldino F Jr, Geller HM. Effect of sodium valproate on hypothalamic neurons in vivo and in vitro. Brain Res 1981;219:231–7.
   Google Scholar
• Gallagher JP, Inokuchi H, Nakamura J, Shinnick-Gallagher P. Effects of anticonvulsants on excitability and GABA sensitivity of cat dorsal root ganglion cells. Neuropharmacology 1981;20:427–33.
   Google Scholar
• Kupferberg HJ, Lust WD, Penry JK. Anticonvulsant activity of dipropylacetic acid (DPA) in relation to GABA and cGMP brain levels in mice [Abstract]. Fed Proc 1975;34:283.
   Google Scholar
• Nau H, Loscher W. Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and -y-aminobutyric acid (GABA) metabolism in the mouse. J Pharmacol Exp Ther 1982;220:654–9.
   PubMed Web of Science ®Google Scholar
• Anlezark G, Horton RW, Meldrium BS, Sawaya CB. Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of -y-aminobutyric acid (GABA) in mice with audiogenic seizures. Biochem Pharmacol 1976;25:413–7.
   PubMedGoogle Scholar
• KerwinRW, TabernerPV. The mechanism of action of sodium valproate. Gen Pharmacol 1981;12:71–5.
   Google Scholar
• Petty F, Rush AJ, Davis JM, Calabrese JR, Kimmel SE, Kramer GL, et al. Plasma GABA predicts acute response to divalproex in mania. Biol Psychiatry 1996;39:278–84.
   PubMedGoogle Scholar
• Perreault P, Tancredi V, Avoli M. Failure of the antiepileptic drug valproic acid to modify synaptic and non-synaptic responses of CAI hippocampal pyramidal cells maintained ‘in vitro.’ Epilepsy Res 1989;3:227–31.
   Google Scholar
• McLean MJ, Macdonald RL. Sodium valproate, but not etho-suximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther 1986; 237:1001–11.
   PubMed Web of Science ®Google Scholar
• VanDongen AM, VanErp MG, Voskuyl RA. Valproate reduces excitability by blockage of sodium and potassium conductance. Epilepsia 1986;27:177–82.
   PubMed Web of Science ®Google Scholar
• Zona C, Avoli M. Effects induced by the antiepileptic drug valproic acid upon the ionic currents recorded in rat neocorti-cal neurons in cell culture. Exp Brain Res 1990;81:313–7.
   PubMed Web of Science ®Google Scholar
• McElroy SL, Keck PE Jr, Stanton SP, Tugrul KC, Bennett JA, Strakowski SM. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 1996;57:142–6.
   PubMed Web of Science ®Google Scholar
• Hirschfeld RMA, Allen MH, McEvoy JP, Keck PE Jr, Russell JM. Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. J Clin Psychiatry 1999; 60:815–8.
   PubMed Web of Science ®Google Scholar
• Francis J, Burnham WM. [3H]Phenytoin identifies a novel anticonvulsant-binding domain on voltage-dependent sodium channels. Mol Pharmacol 1992;42:1097–103.
   PubMed Web of Science ®Google Scholar
• Brouillette WJ, Jestkov VP, Brown ML, Akhtar MS, DeLorey TM, Brown GB. Bicyclic hydantoins with a bridgehead nitrogen: comparison of anticonvulsant activities with binding to the neuronal voltage-dependent sodium channel. J Med Chem 1994;37:3289–93.
   PubMed Web of Science ®Google Scholar
• Kuo CC, Bean BP. Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons. Mol Pharmacol 1994;46:716–25.
   PubMed Web of Science ®Google Scholar
• XuYQ, Pickoff AS, Clarkson CW. Evidence for developmental changes in sodium channel inactivation gating and sodium channel block by phenytoin in rat cardiac myocytes. Circ Res 1991;69:644–56.
   Google Scholar
• Matsuki N, Quandt FN, Ten Eick RE, Yeh JZ. Characterization of the block of sodium channels by phenytoin in mouse neuroblastoma cells. J Pharmacol Exp Ther 1984;228:523–30.
   PubMed Web of Science ®Google Scholar
• Willow M, Gonoi T, Catterall WA. Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamaze-pine on voltage-sensitive sodium channels in neuroblastoma cells. Mol Pharmacol 1985;27:549–58.
   PubMed Web of Science ®Google Scholar
• Kalinowsky LB, Putnam TJ. Attempts at treatment of schizophrenia and other non-epileptic psychoses with dilan-tin. Arch Neurol Psychiatry 1943;49:414–20.
   Google Scholar
• Freyhan FA. Effectiveness of diphenylhydantoin in management of nonepileptic psychomotor excitement states. Arch Neurol Psychiatry 1945;53:370–4.
   Google Scholar
• Kubanek JL, Rowell RC. The use of dilantin in the treatment of psychotic patients unresponsive to other treatments. Dis Nerv System 1946;7:47–50.
   Google Scholar
• McElroy SL, Keck PE Jr. Antiepileptic drugs. In: Schatzberg AF, Nemeroff CB, eds. The American Psychiatric Press textbook of psychopharmacology. Washington, DC: American Psychiatric Press, 1995:351–75.
   Google Scholar
• Post RM. Prophylaxis of bipolar affective disorders. Int Rev Psychiatry 1990;2:277–320.
   Google Scholar
• Belmaker RH, MishoryA, Yaroslavsky U, Lokshin P. Phenyt-oin in mania: a double-blind controlled trial [Abstract]. Biol Psychiatry 1999;45(8, suppl):64S.
   Google Scholar
• Matsuo F, Bergen D, Faught E, Messenheimer JA, Dren AT, Rudd GD, et al. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 1993;43:2284–91.
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:476–9.
   PubMed Web of Science ®Google Scholar
• Kusumakar V, Yatham LN. Lamotrigine treatment of rapid cycling bipolar disorder [Letter]. Am J Psychiatry 1997;154:1171–2.
   PubMedGoogle Scholar
• Walden J, Hesslinger B, Van Calker D, Berger M. Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder. Pharmacopsychiatry 1996; 29:193–5.
   PubMed Web of Science ®Google Scholar
• Fogelson DL, Sternbach H. Lamotrigine treatment of refractory bipolar disorder. J Clin Psychiatry 1997;58:271–3.
   PubMedGoogle Scholar
• Kusumakar V, Yatham LN. An open study of lamotrigine in refractory bipolar depression. Psychiatry Res 1997;72:145–8.
   PubMed Web of Science ®Google Scholar
• Sporn J, Sachs G. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psycho-pharmacol 1997;17:185–9.
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999;60:79–88.
   PubMed Web of Science ®Google Scholar
• Leach MJ, Baxter MG, Critchley MA. Neurochemical and behavioral aspects of lamotrigine. Epilepsia 1991;32(suppl 2): S4–8.
   Google Scholar
• Lees G, Leach MJ. Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex. Brain Res 1993;612:190–9.
   PubMed Web of Science ®Google Scholar
• Taylor CP Gabapentin: mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. 4th ed. New York: Raven, 1995:829–42.
   Google Scholar
• Pande AC. Combination treatment in bipolar disorders [Abstract]. Bipolar Disord 1999;1(suppl 1):17.
   Google Scholar
• Coppen A, Shaw DM, Malleson A, Costain R. Mineral metabolism is mania. BMJ 1966;5479:71–5.
   Google Scholar
• Shaw DM. Mineral metabolism, mania, and melancholia. BMJ 1966;5508:262–7.
   Google Scholar
• Naylor GJ, McNamee HB, Moody JP Changes in erythrocyte sodium and potassium on recovery from a depressive illness. Br J Psychiatry 1971;118:219–23.
   PubMedGoogle Scholar
• Looney SW, El-Mallakh RS. Meta-analysis of erythrocyte Na,K-ATPase activity in bipolar illness. Depress Anxiety 1997;5:53–65.
   PubMedGoogle Scholar
• El-Mallakh RS, Wyatt RJ. The Na,K-ATPase hypothesis for bipolar illness. Biol Psychiatry 1995;37:235–44.
   PubMed Web of Science ®Google Scholar
• Dubovsky SL, Christiano J, Daniell LC, Franks RD, Murphy J, Adler L, et al. Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. Arch Gen Psychiatry 1989;46:632–8.
   PubMed Web of Science ®Google Scholar
• Dubovsky SL, Lee C, Christiano J, Murphy J. Elevated platelet intracellular calcium concentration in bipolar depression. Biol Psychiatry 1991;29:441–50.
   PubMed Web of Science ®Google Scholar
• Dubovsky SL, Murphy J, Thomas M, Rademacher J. Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. Am J Psychiatry 1992; 149: 118–20.
   PubMed Web of Science ®Google Scholar
• Naylor GJ, Smith AH. Defective genetic control of sodium-pump density in manic depressive psychosis. Psychol Med 1981;11:257–63.
   PubMed Web of Science ®Google Scholar
• Wood AJ, Smith CE, Clarke EE, Cowen PJ, Aronson JK, Grahame-Smith DG. Altered in vitro adaptive responses of lymphocyte Na+,K+-ATPase in patients with manic depressive psychosis. J Affect Disord 1991;21:199–206.
   PubMed Web of Science ®Google Scholar
• Li R, El-Mallakh RS. Sodium pump response to ethacrynate in bipolar illness. Presented at the 36th annual meeting of the American College of Neuropsychopharmacology Ka-muela, Hawaii, December 1997.
   Google Scholar
• Vates TS Jr, Bonting SL, Oppelt WW. Na-K activated adenosine triphosphatase in the formation of cerebrospinal fluid in the cat. Am J Physiol 1964;206:1165–72.
   Google Scholar
• Coppen AJ. Abnormality of the blood–cerebrospinal fluid barrier of patients suffering from a depressive illness. J Neurol Neurosurg Psychiatry 1960;23:156–61.
   Google Scholar
• Carroll BJ. Sodium and potassium transfer to CSF in severe depression. In: Davies B, Carroll BJ, Mowbray RM, eds. Depressive illness; some research studies. Springfield, Illinois: Thomas, 1972:249–57.
   Google Scholar
• Rose AM, Mellett BJ, Valdes R Jr, Kleinman JE, Herman MM, Li R, et al. Alpha2 isoform of the Na,K–adenosine triphosphatase is reduced in temporal cortex of bipolar individuals. Biol Psychiatry 1998;44:892–7.
   PubMed Web of Science ®Google Scholar
• Delamere NA, Dean WL, Stidam JM, Moseley AE. Influence of amphotericin B on the sodium pump of porcine lens epithelium. Am J Physiol 1996;270:C465–73.
   Google Scholar
• Frazer A, Mendels J, Brunswick D. Transfer of lithium ions across the erythrocyte membrane. Comm Psychopharmacol 1977;1:255–70.
   Google Scholar
• Lieberman KW, Stokes PE, Van der Noot G. Lithium metabolism and intracellular electrolytes. Brain Res Bull 1978;3:415–8.
   Google Scholar
• Swann AC, Berman N, Frazer A, Koslow SH, Maas JW, Pan-dey GN, et al. Lithium distribution in mania: single-dose pharmacokinetics and sympathoadrenal function. Psychiatry Res 1990;32:71–84.
   Google Scholar
• James PF, Grupp IL, Grupp G, Woo AL, Askew GR, Croyle ML, et al. Identification of a specific role for the Na,K-ATPase a2 isoform as a regulator of calcium in the heart. Mol Cell 1999;3:555–63.
   PubMed Web of Science ®Google Scholar
• Balduini W, Costa LG. Characterization of ouabain-induced phosphoinositide hydrolysis in brain slices of the neonatal rat. Neurochem Res 1990;15:1023–9.
   Google Scholar
• Lichtstein D, Samuelov S. Endogenous ‘ouabain like’ activity in rat brain. Biochem Biophys Res Commun 1980;96:1518–23.
   PubMed Web of Science ®Google Scholar
• Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, et al. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci USA 1991;88:6259–63.
   PubMed Web of Science ®Google Scholar
• Qazzaz HMA, Valdes R Jr. Simultaneous isolation of endogenous digoxin-like immunoreactive factor, ouabain-like factor, and deglycosylated congeners from mammalian tissues. Arch Biochem Biophys 1996;328:193–200.
   Google Scholar
• Grider G, El-Mallakh RS, Huff MO, Buss TJR, Miller J, Valdes R Jr. Endogenous digoxin-like immunoreactive factor (DLIF) serum concentrations are decreased in manic bipolar patients compared to normal controls. J Affect Disord 1999; 54:261–7.
   PubMedGoogle Scholar
• Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992; 149:999–1010.
   PubMed Web of Science ®Google Scholar
• Post RM, Weiss SRB. Sensitization and kindling phenomena in mood, anxiety, and obsessive-compulsive disorders: the role of serotonergic mechanisms in illness progression. Biol Psychiatry 1998;44:193–206.
   PubMedGoogle Scholar
• Cooper DR, Hernandez H, Kuo JY, Farese RV. Insulin increases the synthesis of phospholipid and diacylglycerol and protein kinase C activity in rat hepatocytes. Arch Biochem Biophys 1990;276:486–94.
   PubMed Web of Science ®Google Scholar
• Kim J, Rushovich EH, Thomas TP, Ueda T, Agranoff BW, Greene DA. Diminished specific activity of cytosolic protein kinase C in sciatic nerve of streptozocin-induced diabetic rats and its correction by dietary myo-inositol. Diabetes 1991;40:1545–54.
   PubMed Web of Science ®Google Scholar
• Das PK, Bray GM, Aguayo AJ, Rasminsky M. Diminished ouabain-sensitive sodium-potassium ATPase activity in sciatic nerves of rats with streptozotocin-induced diabetes. Exp Neurol 1976;53:285–8.
   PubMedGoogle Scholar
• Sonobe M, Yasuda H, Hisanaga T, Maeda K, Yamashita M, Kawabata T, et al. Amelioration of nerve Na+-K+-ATPase activity independently of myo-inositol level by PGE1 analogue OP-1206 a-CD in streptozocin-induced diabetic rats. Diabetes 1991;40:726–30.
   PubMed Web of Science ®Google Scholar
• Kim J, Kyriazi H, Greene DA. Normalization of Na+-K+-ATPase activity in isolated membrane fraction from sciatic nerves of streptozocin-induced diabetic rats by dietary myoinositol supplementation in vivo or protein kinase C agonists in vitro. Diabetes 1991;40:558–67.
   PubMed Web of Science ®Google Scholar
• El-Mallakh RS, Li R. Is the Na+-K+-ATPase the link between phosphoinositide metabolism and bipolar disorder? J Neuropsychiatry Clin Neurosci 1993;5:361–8.
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 2000;61:841–50.
   PubMed Web of Science ®Google Scholar